We found that Arf6-KD reduced Rab5 and Rab22 activation in liver cancer cells, and such reductions were recovered by Arf6(wt), especially Arf6(Q67L) over-expression (Fig. 3). The gene discussed is RAB5A; the disease is liver cancer.